Home 5 Conditions 5 Geniculate Neuralgia

Neurovascular Compression

Geniculate Neuralgia

A rare cause of severe, stabbing pain deep in the ear — often described as an ‘ice pick in the ear’.

In brief

Sudden, severe, electric-shock or stabbing pain felt deep in the ear canal
Caused by irritation of the nervus intermedius, part of the facial nerve
One of the rarest of the facial pain syndromes
Diagnosis rests on a careful history; MRI helps exclude other causes
Treated with medication and, when needed, microvascular decompression

What is Geniculate Neuralgia?

Geniculate neuralgia (GN), also known as nervus intermedius neuralgia, is a rare condition characterised by sudden, severe, stabbing or electric shock-like pain felt deep within the ear canal. It is caused by irritation or compression of the nervus intermedius — a small but functionally important branch of the facial nerve (the seventh cranial nerve). The condition is sometimes described as an “ice pick in the ear” due to the intensity and character of the pain. GN is one of the rarest of all the cranial neuralgias, with fewer than 150 cases documented in the English-language medical literature between 1932 and 2012. Population studies estimate the annual incidence of trigeminal neuralgia at approximately 4.7 per 100,000 people and glossopharyngeal neuralgia at approximately 0.8 per 100,000, whereas geniculate neuralgia is rarer still — too uncommon for a reliable population incidence or prevalence to have been established. It can affect either sex, although the limited available data suggest a possible slight female predominance, and can occur at any age, though it most commonly presents in middle-aged adults (mean age of presentation approximately 45 years). It is almost always unilateral (one side only).

What Causes Geniculate Neuralgia?

The nervus intermedius is a small neural structure that travels closely alongside the facial nerve between the seventh and eighth cranial nerves as they exit the brainstem. Despite its small size, it carries important functions including taste sensation from the front of the tongue, control of tear and saliva glands, and sensation from part of the outer ear canal.

In about half of cases, an identifiable cause is found: a blood vessel — most often a branch of the anterior inferior cerebellar artery, and less commonly the posterior inferior cerebellar artery or vertebral artery — compressing the nervus intermedius at its root entry zone near the brainstem. This neurovascular conflict is the same mechanism responsible for trigeminal neuralgia and hemifacial spasm.

Less common causes include:

Tumours or cysts in the posterior fossa compressing the nervus intermedius or facial nerve

Concurrent involvement of the trigeminal or glossopharyngeal nerves is common. In the largest published surgical series, most patients with GN also had trigeminal neuralgia, and approximately one third had both trigeminal and glossopharyngeal neuralgia at the same time. Where several nerves are involved, treatment usually needs to address all of them together rather than the nervus intermedius alone.

In some cases, no identifiable cause is found and the condition is termed idiopathic GN.

What are the Symptoms?

The pain of geniculate neuralgia is typically described as sudden, severe, stabbing, or electric shock-like, felt deep within the ear. Patients frequently describe it as feeling like an ice pick being stabbed into the ear. Attacks are characteristically brief (seconds to minutes), occur unpredictably, and may be triggered by:

Touching the outer ear or the posterior wall of the ear canal
Swallowing, chewing, or yawning
Talking or laughing
Hot showers or changes in temperature

Between attacks, patients are typically pain-free, though some experience a background dull ache in and around the ear.

Because the nervus intermedius carries multiple functions beyond just pain, some patients also notice associated symptoms during attacks, including:

Changes in tear production (excessive tearing or dry eye)
Altered taste or a bitter taste at the front of the tongue
Changes in salivary flow
Sensations within the nose or palate

An important clinical feature worth noting is the frequent overlap with other cranial neuralgias: a significant proportion of patients with GN also have trigeminal neuralgia or glossopharyngeal neuralgia at the same time, and it is not uncommon for all three to coexist. This complexity means that a careful and thorough assessment by an experienced specialist is essential.

A further diagnostic challenge is that trigeminal neuralgia and glossopharyngeal neuralgia can each, in their own right, cause severe lancinating pain felt in or referred to the ear, even when geniculate neuralgia is not present. Ear pain alone therefore does not distinguish between these conditions and can further complicate the diagnosis.

What Conditions Can be Confused with Geniculate Neuralgia?

GN is frequently misdiagnosed, often for prolonged periods, because ear pain (otalgia) has a broad differential diagnosis. Accurate diagnosis is essential as management differs significantly between conditions:

Ramsay Hunt syndrome (herpes zoster of the geniculate ganglion) — this is a distinct condition rather than a form of geniculate neuralgia. It is a viral neuropathy of the nervus intermedius, classified separately, and causes ear pain with a blistering rash in the ear canal and facial weakness. It is distinguished by the rash, viral prodrome, and facial nerve involvement. Because the mechanism is infective rather than compressive, it is treated with antiviral medication and corticosteroids, and is not corrected by microvascular decompression.
Glossopharyngeal neuralgia — pain in the throat, tonsil, and ear; distinguished by the trigger (primarily swallowing) and location (throat and base of tongue rather than deep ear canal alone)
Trigeminal neuralgia — electric shock-like pain in the face, jaw, or teeth; distinguished by location; however, can coexist with GN
Otitis media or externa — middle or outer ear infection; typically associated with discharge, fever, and tenderness on examination
Temporomandibular joint (TMJ) dysfunction — jaw joint pain referred to the ear; typically more constant, related to jaw movement, and associated with joint tenderness on palpation
Eagle’s syndrome — an elongated styloid bone in the neck causing referred throat and ear pain; diagnosed on CT imaging
Cholesteatoma — an abnormal skin growth in the middle ear causing ear pain and discharge; excluded by otoscopy and CT
Referred pain from dental or tonsillar pathology — toothache or tonsillar infection can cause ear pain; excluded by dental and ENT examination

How is Geniculate Neuralgia Diagnosed?

GN is primarily a clinical diagnosis, made on the basis of the characteristic history of pain attacks and a thorough examination. There is no single confirmatory test. Exclusion of other, more common causes of ear pain is an essential first step. In many respects geniculate neuralgia is a diagnosis of exclusion, and other causes of ear pain must be confidently ruled out before it is accepted.

Clinical History and Examination

The distribution and character of the pain, its triggers, and any associated symptoms are carefully documented. It is appropriate that every patient in whom this diagnosis is being considered is formally reviewed by a consultant ear, nose and throat (ENT) surgeon to exclude structural or inflammatory ear disease before geniculate neuralgia is diagnosed. A neurological assessment, dental review and audiological (hearing) assessment are also undertaken to exclude the common causes of otalgia.

Magnetic Resonance Imaging (MRI)

An MRI of the brain is the most important investigation. Specialised high-resolution sequences allow the neurosurgeon to visualise the nervus intermedius and facial nerve at their exit zone from the brainstem and identify whether a blood vessel is compressing them. The other important sequence is an MR angiogram, which helps to define the blood vessel responsible for the compression. MRI is also important to exclude other causes of deep ear pain such as tumour, acoustic neuroma, or other posterior fossa pathology. It is important to understand that geniculate neuralgia remains fundamentally a clinical diagnosis. A small blood vessel lying close to the nerve is a common finding on MRI in people without any symptoms, so imaging serves to support the diagnosis and to plan surgery — not to make the diagnosis on its own. CT imaging may be added if Eagle’s syndrome or cholesteatoma is suspected.

Multidisciplinary Assessment

Given the rarity and complexity of GN, assessment by a neurosurgeon, ENT surgeon, dentist and audiologist is recommended before the diagnosis is established and treatment is embarked upon. In practice this is rarely a formal multidisciplinary meeting; rather, each of these assessments should have taken place independently. Ultimately, the neurosurgeon who is considering surgery is responsible for ensuring that all of these assessments have been completed and that alternative causes of ear pain have been properly excluded.

How is Geniculate Neuralgia Treated?

There are two main treatment strategies: medical management (medications) and surgery. Medical management is always the first-line approach, and surgery is reserved for those whose pain cannot be adequately controlled with medication.

Medical Management — First-Line Treatment

Medications are the first treatment offered to all patients with GN. They do not address the underlying nerve compression but can effectively control the pain attacks in many patients. Because geniculate neuralgia is so rare, no medication has ever been formally tested in a clinical trial for this condition. Drug treatment is therefore based on a small number of published cases and on experience with trigeminal neuralgia, a closely related condition caused by the same mechanism.

Carbamazepine (Tegretol) is the best-supported and most widely used first-line medication for GN, and the same drug used for trigeminal neuralgia. It works by stabilising abnormally excitable nerve membranes. In the published geniculate neuralgia literature, carbamazepine produced a good response in approximately 60% of reported cases. It is started at a low dose and gradually increased until pain control is achieved. Common side effects include drowsiness, dizziness, and — particularly in elderly patients — low sodium levels in the blood. Blood tests are required to monitor for rare effects on blood counts, liver function, and sodium levels.

Oxcarbazepine (Trileptal) is regarded as an equally appropriate first-choice alternative to carbamazepine. It works in the same way and is often better tolerated, with fewer drug interactions and less blood-test monitoring required. Major international guidelines for trigeminal neuralgia recommend carbamazepine and oxcarbazepine together as the drugs of first choice.

Gabapentin (Neurontin) is the next agent usually considered if carbamazepine or oxcarbazepine are ineffective or poorly tolerated. Aside from carbamazepine, it is the only drug with any geniculate-neuralgia-specific supporting data, having produced a good response in a small number of reported cases. Pregabalin (Lyrica) works in a similar way and may be used as an alternative.

Other medications are sometimes tried when the above are unsuccessful, including lamotrigine, baclofen, amitriptyline, and phenytoin, used individually or in combination. It should be understood that there is little or no geniculate-neuralgia-specific evidence for any of these, and their use is extrapolated from the treatment of trigeminal neuralgia.

Standard over-the-counter pain relievers such as paracetamol, ibuprofen, and aspirin are not effective for neuralgic pain and are not recommended as primary treatment.

For pain caused by Ramsay Hunt syndrome (herpes zoster), antiviral medication (aciclovir or valaciclovir), usually combined with a corticosteroid, is required alongside standard pain management. This antiviral and corticosteroid combination is only of benefit when started early, within the first week of the onset of symptoms; once this window has passed it offers no benefit.

Surgical Treatment

Surgery is reserved for patients whose pain cannot be adequately controlled with medications and whose overall health makes surgery appropriate. Given the rarity of GN, the published surgical experience consists predominantly of small case series and individual reports rather than large-scale trials.

Microvascular Decompression (MVD)

MVD directly addresses the underlying cause of GN by moving the offending blood vessel away from the nervus intermedius at the brainstem. It requires a general anaesthetic and an opening in the skull behind the ear (retrosigmoid craniotomy). The nervus intermedius lies on the far side of the seventh and eighth cranial nerve complex, which makes it difficult to see using the traditional operating microscope alone. The addition of a surgical endoscope — particularly a 30-degree angled endoscope — is very helpful in this setting, allowing the anatomy around the nerves to be directly visualised without the need for retraction to gain a line of sight. The nervus intermedius is identified, the compressing vessel moved aside, and a small Teflon felt cushion placed to maintain separation. MVD preserves the nervus intermedius and avoids the permanent deficits associated with nerve section, which may affect not only sensation but also tear production and salivary flow. When a clear neurovascular conflict is identified on imaging, MVD is the preferred initial surgical approach. Overall, favourable pain outcomes (improvement or complete resolution) are reported in the majority of patients in published series.

Nervus Intermedius Sectioning (Neurectomy)

When no compressing vessel is identified, or when MVD alone does not provide adequate relief, sectioning (cutting) of the nervus intermedius may be performed. This can be done at the time of MVD or as a standalone procedure. In the largest published experience, pain improved after approximately 81% of procedures and resolved completely after approximately 68% at latest follow-up. Complications were uncommon: two cases of unexpected hearing loss, one case of permanent vestibular dysfunction, no instances of permanent facial paralysis, and three cases of altered taste. In an earlier large series of 64 patients treated with NI and geniculate ganglion excision, sustained pain relief was reported in the majority at long-term follow-up, with preserved facial nerve function in all cases. Importantly, some degree of altered taste or dry eye on the affected side can occur following neurectomy, as a result of interruption of NI fibres supplying the taste and lacrimal pathways. This should be discussed with each patient in detail prior to surgery.

Combined Surgery

As GN frequently coexists with trigeminal neuralgia or glossopharyngeal neuralgia, where more than one nerve is clearly involved the operation may need to address each of them in the same procedure. Some published series report better overall pain outcomes with this approach. It should be emphasised that this refers to treating nerves that are themselves symptomatic; routine sectioning of additional nerves is not standard practice and would not be undertaken without a clear clinical indication discussed with you beforehand. All surgery for GN should be performed by a neurosurgeon with specific experience in posterior fossa and skull base surgery, at a centre with appropriate operative expertise.

What Happens if Geniculate Neuralgia is Left Untreated?

GN is not life-threatening and does not damage the brain. For patients whose pain is well controlled on medication, conservative management is entirely appropriate. Without treatment, the pain attacks typically persist and can significantly impair quality of life — eating, talking, and even touching the ear may provoke severe attacks. Spontaneous remission can occur but is unpredictable. GN does not shorten life expectancy.

References

Helpful links

The resources below are written primarily for doctors rather than patients, but there is very little reliable patient-focused information available on this rare condition.
International Classification of Headache Disorders (ICHD-3) — nervus intermedius neuralgia
Tubbs RS et al. The nervus intermedius: a review of its anatomy, function, pathology, and role in neurosurgery
Ren AL et al. Nervus intermedius sectioning for the treatment of geniculate neuralgia (free full-text PDF available)

Microvascular decompression (MVD) — procedure animation A short medical animation of how the operation works



Geniculate Neuralgia — patient information sheet PDF · prepared by Mr Jeremy Russell

Download PDF

Content on this page is for education and information only and is not a substitute for advice from your doctor. Medically reviewed by Mr Jeremy Russell.